DOYLE THOMAS JAMES
SVP, Finance & Accounting · 10 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-27 | KURA | Kura Oncology, Inc. | Sale | 2,226 | $8.46 | $18,833.52 | filing |
| 2026-01-27 | KURA | Kura Oncology, Inc. | Sale | 2,226 | $8.46 | $18,833.52 | filing |
| 2026-01-27 | KURA | Kura Oncology, Inc. | Sale | 1,114 | $8.46 | $9,425.22 | filing |
| 2026-01-27 | KURA | Kura Oncology, Inc. | Sale | 881 | $8.46 | $7,453.88 | filing |
| 2026-01-27 | KURA | Kura Oncology, Inc. | Sale | 695 | $8.46 | $5,880.19 | filing |
| 2026-01-02 | KURA | Kura Oncology, Inc. | Award | 21,250 | $0.00 | $0.00 | filing |
| 2025-11-14 | KURA | Kura Oncology, Inc. | Sale | 4,539 | $11.18 | $50,731.95 | filing |
| 2025-11-13 | KURA | Kura Oncology, Inc. | Award | 24,967 | $0.00 | $0.00 | filing |
| 2025-09-29 | KURA | Kura Oncology, Inc. | Sale | 4,541 | $8.94 | $40,606.53 | filing |
| 2025-09-27 | KURA | Kura Oncology, Inc. | Award | 24,966 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.